On Thursday, September 26th, BioPortUSA organized its first summit of subject matter experts. We had participants come from as far away as Louisville, KY, Baltimore, MD and Vermont. The main goal was to bring all of our team members together to introduce them to one another, and to examine how we as a collective ecosystem could help ease the market entry process for international life science companies into the United States.[...]
Fust Charles Chambers LLP, a leading accounting firm in Upstate New York,has joined the team at BioPortUSA to better service the needs of international life science companies looking to enter or expand their presence in the USA. [...]
The U.S. Consulate in Düsseldorf, Germany will play host to a VIP Event involving BioPortUSA and EY Life Sciences on November 17th. The presentation titled “Demystifing US Market Entry” will focus on what the international medical device community needs to take into consideration when contemplating market entry into the US healthcare market. The event is slated to take place one day before the start of MEDICA (https://www.medica-tradefair.com/), the worlds largest medical device show[...]
On June 4th, BioPortUSA CEO Mark Lesselroth had the honor to kick off the Global Innovation hub series at BIO in Philadelphia. As a result of this presentation, both Enterprise Singapore and Enterprise Spain reached out to BioPort to enquire how the company could be of service to life science organizations in those respective countries wishing to expand their operations into the United States. [...]
In May 2019, Mark Lesselroth, CEO of BioPortUSA and David Reed, Principal of Reed Business law, had an opportunity to join Jon Wilks our partner at UK HealthGateway to discuss the topic of Brexit and how it could impact US market entry for UK based medtech firms. [...]
Join Mark Lesselroth, CEO of BioPortUSA on June 4th at 1:30pm in theatre A at BIO in Philadelphia, as he kicks off the Global Innovation Hub series - https://bio2019.zerista.com/profile/member/2027233 highlighting why the US is an ideal market for international Biotech firms to invest in.[...]
Mark Lesselroth, CEO of BioPortUSA along with Manfred Kauer, Senior Consultant of BioPortUSA for the D-A-CH region will be attending Bionnale 2019, the largest networking event for life sciences and healthcare industries in Germany.[...]
BioPortUSA announced a new partnership today with BEO Berlin, one of Germany’s leading regulatory consulting firms for the medical device industry. “Having access to BEO Berlin will allow us to better support our US clients in the med-tech field who are interested in expanding into the German market.[...]
Social Media
